16-88829729-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000512.5(GALNS):c.1002+2269G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.218 in 152,262 control chromosomes in the GnomAD database, including 4,384 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.22 ( 4384 hom., cov: 33)
Consequence
GALNS
NM_000512.5 intron
NM_000512.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.482
Publications
13 publications found
Genes affected
GALNS (HGNC:4122): (galactosamine (N-acetyl)-6-sulfatase) This gene encodes N-acetylgalactosamine-6-sulfatase which is a lysosomal exohydrolase required for the degradation of the glycosaminoglycans, keratan sulfate, and chondroitin 6-sulfate. Sequence alterations including point, missense and nonsense mutations, as well as those that affect splicing, result in a deficiency of this enzyme. Deficiencies of this enzyme lead to Morquio A syndrome, a lysosomal storage disorder. [provided by RefSeq, Jul 2008]
GALNS Gene-Disease associations (from GenCC):
- mucopolysaccharidosis type 4AInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.521 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GALNS | ENST00000268695.10 | c.1002+2269G>A | intron_variant | Intron 9 of 13 | 1 | NM_000512.5 | ENSP00000268695.5 | |||
GALNS | ENST00000562593.5 | n.4411+2269G>A | intron_variant | Intron 7 of 11 | 1 | |||||
GALNS | ENST00000567525.5 | n.*473+2269G>A | intron_variant | Intron 7 of 11 | 2 | ENSP00000454484.1 | ||||
GALNS | ENST00000568613.5 | n.*965+2269G>A | intron_variant | Intron 10 of 14 | 2 | ENSP00000457921.1 |
Frequencies
GnomAD3 genomes AF: 0.218 AC: 33198AN: 152144Hom.: 4389 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
33198
AN:
152144
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.218 AC: 33200AN: 152262Hom.: 4384 Cov.: 33 AF XY: 0.221 AC XY: 16428AN XY: 74436 show subpopulations
GnomAD4 genome
AF:
AC:
33200
AN:
152262
Hom.:
Cov.:
33
AF XY:
AC XY:
16428
AN XY:
74436
show subpopulations
African (AFR)
AF:
AC:
3443
AN:
41580
American (AMR)
AF:
AC:
3757
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
904
AN:
3470
East Asian (EAS)
AF:
AC:
2777
AN:
5168
South Asian (SAS)
AF:
AC:
1196
AN:
4830
European-Finnish (FIN)
AF:
AC:
2864
AN:
10600
Middle Eastern (MID)
AF:
AC:
81
AN:
294
European-Non Finnish (NFE)
AF:
AC:
17288
AN:
68012
Other (OTH)
AF:
AC:
541
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1301
2602
3904
5205
6506
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1139
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.